Roth, Thomas
Funding for this research was provided by:
Avadel Pharmaceuticals
Article History
Received: 14 December 2023
Accepted: 22 March 2024
First Online: 25 May 2024
Declarations
:
: Thomas Roth is a consultant for Jazz Pharmaceuticals, Takeda Pharmaceutical Co., Orexo, Avadel Pharmaceuticals, Eisai, Merck & Co., and Idorsia.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.